|
 |
|
|
| Breaking News on Laboratory Equipment |
||
|
||
| Daily
18-Mar-2008 |
 Forward to a colleague |
|
|
Access Full Stories  Applied Bio sequences a human genome for $60,000Applied Biosystems has sequenced a human genome for $60,000 in a project that sets the scene for an interesting price war between DNA sequencing tool specialists... Read Synthetic biology research centre established in NL The University if Groningen in the Netherlands has established a new research centre dedicated to the growing discipline of synthetic biology and its application to the production of biologic medicines... Read Peptide Technologies extends synthesis range with new Tribute Peptide Technologies showcased their latest rapid automated peptide synthesis equipment at Pittcon 2008, including a new product, the benchtop Tribute instrument... Read FDA makes progress in plans for China presence The US Food and Drug Administration (FDA) has alerted the media that it has taken a significant step forward in its plans to establish a presence on the ground in China... Read Laboratory product news in brief LabTechnologist.com presents a round-up of new products that have been introduced to the laboratory equipment market of late, including items from Applied Biosystems, Olympus, Gentronix and Radleys... Read |
|
|||||||||||||||
All News Headlines for: March | February | January |
|||||||||||||||||
|
Related Industry News Crucell, DSM hit 15g/L milestone with PER.C6 technology Dutch biotech Crucell and its US partner DSM Biologics have achieved a record yield of 15 grams per litre with their PER.C6 cell line technology for the production of monoclonal antibodies and recombinant proteins... Read Emerging market challenges no hindrance to pharma Despite the challenges that emerging market present, such as intellectual property (IP) exposure and drug pricing controls, the pharma industry is not being deterred... Read Cognizant inks $95m AstraZeneca data deal Cognizant is gaining ground in the life sciences arena, this week inking a $95m data management deal with AstraZeneca, just three months after sealing another multi-million dollar deal with Merck & Co... Read Pharmaceutical traces in water 'highly unlikely to harm', says industry Politicians in the US have gone on the offensive while regulators and industry groups have circled their wagons over a five-month investigation by the Associated Press that has rung alarm bells about trace levels... Read
|
|||||||||||||||||
|
|
|
|||
| Forward to a colleague |
|||||
|
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
|
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||
